중동 및 아프리카 급성 관상동맥증후군 시장 – 2029년까지의 산업 동향 및 예측

중동 및 아프리카 급성 관상 동맥 증후군 시장 분석 및 통찰력

중동 및 아프리카 급성 관상동맥증후군 시장은 2022년에서 2029년의 예측 기간 동안 상당한 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년에서 2029년의 예측 기간 동안 3.9%의 CAGR로 성장하고 있으며 2029년까지 2억 6,677만 달러에 도달할 것으로 예상된다고 분석했습니다. 중동 및 아프리카 급성 관상동맥증후군 시장 성장을 견인하는 주요 요인은 관상동맥질환, 허혈성 심장질환, 혈관질환과 같은 만성 질환의 유병률 증가, 노인 인구 증가, 시장 참여자가 제공하는 광범위한 제품 범위로 인해 급성 관상동맥증후군 시장이 미래에 성장할 것입니다.

급성 관상동맥증후군은 심장으로 가는 혈류가 감소하는 질병군을 말합니다. ACS와 관련된 상태에는 ST 상승 심근경색(STEMI), 비ST 상승 심근경색(NSTEMI), 불안정 협심증이 있습니다. 이것은 관상동맥 심장병(CHD)의 한 유형으로, 35세 이상의 사람들의 총 사망자의 3분의 1을 차지합니다. 일부 형태의 CHD는 무증상일 수 있지만 ACS는 항상 증상이 있습니다.

급성 관상동맥증후군(ACS)은 관상 동맥심장질환(CHD) 의 증상 이며 일반적으로 관상동맥의 플라그 파괴(죽상경화증)의 결과입니다. 이 질환의 일반적인 위험 요인은 흡연, 고혈압, 당뇨병, 고지혈증, 신체 활동 부족, 가족 비만 및 영양 부족입니다. 코카인 남용은 또한 혈관경련으로 이어질 수 있습니다. 조기 심근경색(55세)의 가족력도 고위험 요인입니다.

중동 및 아프리카 급성 관상동맥증후군 시장 보고서는 시장 점유율, 새로운 개발, 국내 및 지역 시장 참여자의 영향에 대한 세부 정보를 제공하고, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서 기회를 분석합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.

Acute Coronary Syndrome Market Dynamics

Drivers

• Rise in Prevalence of Chronic Diseases, such as Coronary Artery Disease, Ischemic Heart Disease, and Vascular Diseases

As the companies are constantly engaged in research and developmental activities, the knowledge about the prevalence of chronic heart and vascular diseases would help in finding novel solutions, and developing the cardiology and vascular devices would aid in more collaborations and partnerships with market players in the U.S., Europe, and Asia Pacific region. This signifies that the increase in research and development investment for the discovery and development of treatments of acute coronary syndrome boosts the market growth.

• Growing Geriatric Population

The number of elderly people reporting respective cardiovascular diseases is high. Owing to this, it is anticipated that the ever-increasing geriatric population, which is expected to rise in future years worldwide mainly in Middle East and Africa& Asia-Pacific region, creates an opportunity for market growth in the forecast period.

• Wide Range of Products Offered by Market Players

Strategic product launches and collaborations done by major companies in interventional cardiology and peripheral vascular devices have opened up an opportunity to expand their business in various regions. This strategy is allowing the companies to strengthen their footprints in the market. Therefore, it is predicted that strategic initiative is the golden opportunity for the market players to accelerate their revenue growth in the market.

Opportunities

• Surge in Technological Advancements for Cardiovascular Disease

As technology advances rapidly, it improves how one manages cardiovascular diseases. In addition, recent healthcare monitoring applications and gadgets have enhanced the connection between patients and healthcare providers to update treatment plans and improve health outcomes. Thus, this is expected to create a significant opportunity for the Middle East and Africa coronary syndrome market in the forecast period.

Also, Governments in emerging markets (China, Brazil, Russia, India, and South Africa) reform public healthcare and grant more accessible access to medicine. These two factors working in unison mean greater freedom for market developments and increased innovation in clinical research in emerging markets.

Restraints/Challenges

Rise in cost of the therapeutic surgery and lack of accessibility of disease management services and support in low economic countries are the restrains and challenges for the growth of acute coronary syndrome market.

The increased intricacy and cost of the cardiology devices and robust investments would increase the costs. The increased cost would result in delayed treatment of the patients in hospitals and clinics and clearance of these product is very rigorous and time-consuming many of the products find it difficult to get approved due to not complying with the regulations which may hamper the market growth.

This acute coronary syndrome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on acute coronary syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In November 2021, Merck, announced the successful completion of the acquisition of Acceleron Pharma Inc. It is an important and strategic opportunity for company to continue growing their cardiovascular portfolio and pipeline that builds on long and proud legacy in cardiovascular disease and further bolsters company’s business development strategy fueled by Acceleron’s groundbreaking research.

Middle East and Africa Acute Coronary Syndrome Market Scope

Middle East and Africa acute coronary syndrome market is categorized based on type, treatment, diagnosis and end user. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Type

• Non-St-Elevation Myocardial Infarction
• St-Elevation Myocardial Infarction
• Unstable Angina

On the basis of type, the Middle East and Africa acute coronary syndrome market is segmented into non-St-elevation myocardial infarction, St-elevation myocardial infarction and unstable angina.

Diagnosis

• Stress Test
• Blood Tests
• Imaging
• Others

On the basis of diagnosis, the Middle East and Africa acute coronary syndrome market is segmented into stress test, blood test, imagining and others.

Treatment

• Medication
• Surgery

On the basis of treatment, the Middle East and Africa acute coronary syndrome market is segmented into medication and surgery.

End User

• Hospitals and Clinics
• Diagnostic Centers
• Academic Institutes
• Others

On the basis of end user, the Middle East and Africa acute coronary syndrome market is segmented into hospitals and clinics, diagnostic centers, academic institutes and others.

Acute Coronary Syndrome Market Regional Analysis/Insights

Middle East and Africa acute coronary syndrome market is further segmented into major countries including South Africa, Saudi Arabia, U.A.E, Egypt, Israel and Rest of Middle East and Africa.

South Africa in Middle East and Africa dominates the acute coronary market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the well-developed healthcare infrastructure in the country.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Middle East and Africa brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Middle East and Africa Acute Coronary Syndrome Market Share Analysis

Middle East and Africa acute coronary syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to acute coronary syndrome market.

Some of the prominent participants operating in the Middle East and Africa acute coronary syndrome market are Movianto (U.S.), Sharp (U.S.),Thermo Fisher Scientific Inc.,(U.S.), Catalent, Inc (U.S.), PCI Pharma Services (U.S.), Almac Group (U.K.), PAREXEL International Corporation (U.S.), Bionical Ltd. (U.K.), Alium Medical Limited (U.K.), MYODERM (U.K.), Clinigen Group plc (U.K.), Ancillare, LP (U.S.), SIRO Clinpharm (India) CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC. (U.S.) Biocair (U.K.) and others.

Research Methodology

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가 전화를 요청하십시오.

SKU-68014